Rock Springs Capital Management LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Rock Springs Capital Management LP
CRD #168648
SEC #801-78511
CIK #0001735397, 0001595725
AUM $3.3 B (2025-03-14)
Employees 20 (45% Investors, 0% Brokers)
Phone410-220-0130
Address650 S Exeter Street
Baltimore, MD 21202
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($B)
6.04.83.62.41.20.02011201620212026
Sector Form 13F Holdings Value ($B)
Argenx SE 0.1
Lilly Eli & Co 0.1
Merus NV 0.1
Rhythm Pharmaceuticals Inc 0.1
Insmed Inc 0.1
Ultragenyx Pharmaceutical Inc 0.1
Revolution Medicines Inc 0.0
Intuitive Surgical Inc 0.0
Synta Pharmaceuticals Corp 0.0
Mirum Pharmaceuticals Inc 0.0
View All
Holdings by Sector ($B)
6.04.83.62.41.20.02014201820222026
Type Form D Funds Date Sold ($M) AUM ($M)
HF Four Pines Master Fund LP [2020-03-30] 24.0 279.8
HF Rock Springs Capital Master Fund LP [2014-01-22] 2,467.4 3,044.6
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 6 3.3
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 6 3.3
By Discretionary
Discretionary 6 3.3
Non-Discretionary 0 0.0
Total 6 3.3
By Non-United States Persons
Non-United States Persons 0.7
United States Persons 2.6
Total 6 3.3
Form D Directors # Filings # Firms 2011 - 2025
Kris Jenner 7
Gordon Bussard 4
Graham McPhail 4
Rock Springs Capital Management LP 4
Rock Springs General Partner LLC 2
Four Pines General Partner LLC 2
EDGAR Form CIK 2011 - 2025
13F-HR [0001595725]
3 [0001595725]
4 [0001595725]
SC 13G [0001595725]
3 [0001735397]
4 [0001735397]
Form 13D/13G Filer Form 13D/13G Subject Filed
Rock Springs Capital Management LP Aclaris Therapeutics Inc [2024-11-22]
Rock Springs Capital Management LP Travere Therapeutics Inc [2024-05-01]
Rock Springs Capital Management LP Xilio Therapeutics Inc [2024-02-14]
Rock Springs Capital Management LP Agios Pharmaceuticals Inc [2023-02-14]
Rock Springs Capital Management LP Aeglea Biotherapeutics Inc [2023-02-14]
Rock Springs Capital Management LP Inozyme Pharma Inc [2022-04-25]
Rock Springs Capital Management LP Mereo Biopharma Group PLC [2022-02-15]
Rock Springs Capital Management LP Tempest Therapeutics Inc [2022-01-03]
Rock Springs Capital Management LP Compass Therapeutics Inc [2021-12-30]
Rock Springs Capital Management LP Tempest Therapeutics Inc [2021-07-08]
View All
Form 3/4/5 Subject 2011 - 2025
Rock Springs Capital LLC
Rock Springs Capital Management LP
Tempest Therapeutics, Inc.
Rock Springs Capital Master Fund LP
Xilio Therapeutics, Inc.
Four Pines Master Fund LP
Theseus Pharmaceuticals, Inc.
Verve Therapeutics, Inc.
Atea Pharmaceuticals, Inc.
Inozyme Pharma, Inc.
Enliven Therapeutics, Inc.
Q32 Bio Inc.
Alpine Immune Sciences Inc
Dare Bioscience, Inc.
Comparable Firms State AUM ($B)
Darlington Partners Capital Management LP
CA 3.4
Portman Square Capital LLP
3.4
MANE Global Capital Management LP
NY 3.4
Mantle Ridge LP
NY 3.3
Locust Wood Capital Advisers LLC
NY 3.3
Cadian Capital Management LP
NY 3.3
Prana Capital Management LP
CT 3.3
Solus Alternative Asset Management LP
NJ 3.3
Carrhae Capital LLP
3.3
Atom Investors LP
TX 3.3
Terms | Privacy | Guide
tony@aum13f.com